Isolation and Characterization of a Prolactin-Requlating Factor (PRF) from a Mouse Pituitary Intermediate Lobe Cell Line
Year: 2000
Type: article
Abstract: Prolactin (PRL) gene expression and release is regulated by inhibitory and stimulatory factors from the hypothalamus and pituitary.Dopamine is the primary PRL-inhibitory factor, but acute elevations in PRL require stimulation by a PRL-releasing factor (PRF).A PRF peptide that differed from known PRL secretagogues was initially discovered in the rat posterior pituitary (PP).This PRF localized to a subpopulation of pituitary intermediate lobe (IL) cells and it rapidly stimulated PRL release.Partial purification of PRF by sequential chromatography from bovine PP and IL tumors revealed the presence of multiple species that differed in size and chromatographic properties.However, the primary structure of PRF has not been resolved.Our working hypothesis was: a subpopulation of IL cells secretes a novel peptide that functions as a PRF.Transgenic POMC-Tag mice that develop IL tumors were used to investigate the following objectives: 1) determine if POMC-Tag mice with IL tumors develop hyperprolactinemia, 2) establish and characterize an IL cell line the produces PRF, 3) determine the biochemical properties of PRF, 4) purify PRF to homogeneity and determine its amino acid sequence.No hyperprolactinemia was observed in either male or female POMC-Tag mice from day 20 to 120 of tumor progression.Cells from two distinct IL tumors were cloned and expanded into mIL cell lines that differed in morphology and cellular characteristics.As assessed by RT-PCR the mIL39, but not mIL5, cells expressed POMC and D2R gene products, characteristic of IL melanotrophs.The cell lineage of the mIL5 cells remains undefined and they may represent a novel IL cell subtype.Only the mIL5 cells stimulated PRL gene expression and release from coculture with GH3/luc cells.The PRF from mIL5 cells was a secreted product that bound to heparin.Two heparin-binding proteins, FGF2 and HB-EGF, were identified by RT-PCR in mIL5 cells.Both were potent PRL inducers, but they did not significantly contribute to the PRF activity from mIL5 cells as judged by Western blotting, heparin-affinity and immunoneutralization.Purification of PRF from mIL5 cells by heparin-affinity chromatography indicated multiple species that differed in chromatographic properties.Sequential chromatography was used to isolate PRF from mIL5 cell extract and sequencing identified a peptide identical to an internal sequence of murine heparin/heparan-interacting protein (HIP/L29).The expression of HIP protein by RT-PCR was ubiquitous and two anti-HIP antibodies were ineffective in the attenuation of PRF activity from mIL5 cells.Isolated PRF from mIL5-conditioned media was subjected to mass spectrometry that revealed an estimated mass of 14,968 Da.N-terminal sequence analysis failed to resolve the primary structure of PRF.Malcolm Low for generously providing the POMC-Tag mice, Dr. Daniel Carson for his generous gift of two anti-HIP antibodies, Dr. Phillip Andrews in Michigan and the Yale protein core for their expertise in mass spectrometry and protein analysis.I would also like to thank my mentor and friend, Dr. Nira Ben-Jonathan, for her constant support in the following ways: never a closed door and always available, the opportunities to travel as a scientist, all the arguments that made me think, for encouraging my independence, for being stubborn yet open-minded, allowing me to take risks and make mistakes, for perspective, balance and endless encouragement during the emotional extremes.I would like to thank my thesis committee members: Dr Michael Lehman, Dr. Nelson Horseman, Dr. Nancy Ratner and Dr. Neil Richtand
Author: Robert Hnasko
Institution: University of Cincinnati
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2261508705
